肝硬化伴肝昏迷的研究给患者带来了希望

StephenW

Research on cirrhosis with liver coma brings hope for patients

   
Ludhiana, November 25
A collaborative study, which was conducted by Prof Sandeep Singh Sidhu, Department of Gastroenterology, Dayanand Medical College (DMC), Ludhiana, and Prof BC Sharma, Department of GB Pant Hospital, New Delhi, over the past three years, has yielded a breakthrough in treatment of patients with cirrhosis with liver coma.

Prof Sidhu presented his research paper on “L — Ornithine L — Aspartate in the treatment of cirrhosis patients suffering from bouts of liver coma” at the annual meeting of the American Association For Study of Liver Diseases (AASLD), held at Washington DC (USA), from October 20 to 24. His research has also been published in Hepatology Journal of the AASLD.

Earlier, his research paper was awarded Best of Asia Plenary Digestive Week at the Plenary Paper for Presentation, held at Hong Kong on September 25 this year.

Their research has also been accepted by Cochrane Society, London (United Kingdom), for publication. It will now be presented in Hyderabad on December 9 as one the best of research papers of AASLD/ European Association for the Study of Liver (EASL) of the year 2017.

Commenting on his research paper, Dr Sidhu said, “The use of L – Ornithine L – Aspartate (LOLA) offers a ray of hope for patients with cirrhosis suffering from liver coma. Along with the conventional treatment, intravenous infusion of LOLA given over four days, decreases the blood ammonia level, speeds up the recovery of liver coma, shortens the length of hospital stay and is completely safe.”

He said, “Punjab has a huge burden of patients with liver cirrhosis due to alcohol consumption and Hepatitis C.”

Dr Sidhu completed his DM in gastroenterology from the All India Institute of Medical Sciences in 1993.

StephenW

肝硬化伴肝昏迷的研究给患者带来了希望

   
卢迪亚纳，十一月二十五日
过去三年来，新德里大卫医院消化科Sandeep Singh Sidhu，Dayanand Medical College（DMC），Ludhiana和BC Sharma教授共同进行的一项合作研究取得了突破性进展用于肝硬化合并肝昏迷患者的治疗。

Sidhu教授在美国华盛顿特区举行的美国肝病研究协会（AASLD）年会上发表了他关于“L - 鸟氨酸L - 天门冬氨酸治疗肝昏迷期肝硬化患者”的研究论文。 ），从10月20日至24日。他的研究也已发表在“肝脏病学杂志”的AASLD。

此前，他的研究论文在今年9月25日在香港举行的全体会议论文摘要中被授予亚洲最佳消耗周。

他们的研究也被伦敦（英国）的Cochrane协会接受发表。现将于12月9日在海得拉巴举行，作为2017年AASLD /欧洲肝脏研究协会（EASL）的最佳研究论文之一。

Sidhu博士评论他的研究论文时说：“使用L - 鸟氨酸L - 天冬氨酸（LOLA）为患有肝昏迷的肝硬化患者提供了一线希望。随着常规治疗，LOLA静脉滴注4天以上，降低了血氨水平，加快了肝昏迷的恢复，缩短了住院时间，完全安全。

他说：“旁遮普因饮酒和丙型肝炎导致肝硬化患者负担很重。”

Sidhu博士1993年在全印度医学科学院完成了胃肠病学的DM。